Article Type
Changed
Thu, 01/10/2019 - 12:00
Display Headline
Herpes Simplex Virus Prophylaxis With Famciclovir in Patients Undergoing Aesthetic Facial CO2 Laser Resurfacing

Article PDF
Author and Disclosure Information

Emil Bisaccia, MD; Dwight Scarborough, MD

Accepted for publication March 27, 2003. Dr. Bisaccia is from Columbia University, College of Physicians and Surgeons, New York, New York. Dr. Scarborough is from Ohio State University Hospitals, Columbus.
The authors received a research grant from Novartis Pharmaceuticals Corporation for this study.

Issue
Cutis - 72(4)
Publications
Page Number
327-328
Sections
Author and Disclosure Information

Emil Bisaccia, MD; Dwight Scarborough, MD

Accepted for publication March 27, 2003. Dr. Bisaccia is from Columbia University, College of Physicians and Surgeons, New York, New York. Dr. Scarborough is from Ohio State University Hospitals, Columbus.
The authors received a research grant from Novartis Pharmaceuticals Corporation for this study.

Author and Disclosure Information

Emil Bisaccia, MD; Dwight Scarborough, MD

Accepted for publication March 27, 2003. Dr. Bisaccia is from Columbia University, College of Physicians and Surgeons, New York, New York. Dr. Scarborough is from Ohio State University Hospitals, Columbus.
The authors received a research grant from Novartis Pharmaceuticals Corporation for this study.

Article PDF
Article PDF

Issue
Cutis - 72(4)
Issue
Cutis - 72(4)
Page Number
327-328
Page Number
327-328
Publications
Publications
Article Type
Display Headline
Herpes Simplex Virus Prophylaxis With Famciclovir in Patients Undergoing Aesthetic Facial CO2 Laser Resurfacing
Display Headline
Herpes Simplex Virus Prophylaxis With Famciclovir in Patients Undergoing Aesthetic Facial CO2 Laser Resurfacing
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media